Related Experiment Video
Updated: May 2, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
8.8K
New strategies are needed in diffuse malignant mesothelioma
K S Sridhar1, R Doria, W A Raub
1Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, FL 33101.
Cancer
|December 25, 1992
Summary
Survival in malignant mesothelioma patients is linked to earlier stage, good performance, and combined surgery/chemotherapy. Anthracycline chemotherapy shows higher remission rates for this asbestos-related cancer.
Area of Science:
- Oncology
- Epidemiology
- Clinical Medicine
Background:
- Malignant mesothelioma is a rare and aggressive cancer.
- Asbestos exposure is a primary risk factor.
Purpose of the Study:
- To review clinical features of malignant mesothelioma.
- To identify factors influencing patient survival.
Main Methods:
- Retrospective review of medical records for 50 malignant mesothelioma patients.
- Statistical analysis of demographic, clinical, and survival data.
Main Results:
- The male-to-female ratio was 4:1, with a median age of 58 years.
- Pleural mesothelioma (73%) was most common, often diagnosed at later stages (Stage II: 39%).
- Survival was positively associated with earlier stage, good performance status, and combined surgery/chemotherapy.
Conclusions:
- Survival is independent of age, sex, and smoking.
- Anthracycline-based chemotherapy demonstrated higher remission rates compared to non-anthracyclines.
- Future trials should stratify primary and recurrent chemotherapy and incorporate multitechnique approaches.
Related Concept Videos
02:17The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
02:49Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K